This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Steven R DeMeester during the Masters Foregut: Mastering GERD on April 13 2018
Keyword(s): abdominal, ablation, acid, acid suppression therapy, AGA guidelines, American Gastroenterological Assocation, antireflux surgery, ARS, Barretts esophagus, cardia mucosa, complications, dilatation, endoscopic therapy, esophageal adenocarcinoma, esophagus, foregut surgeons, gastric emptying, gastric mucosa, gastroenterologists, gastroenterology, gastroesophageal junction, gastroesophageal reflux disease, GEJ, GERD, HGD, high grade dysplasia, IM, intestinal metaplasia, LES, leukocytes, LGD, LINX, low grade dysplasia, lower esophageal sphincter, masters foregut, medical therapy, meta-analysis, mortality, natural history, Nissen fundoplication, pathophysiology, peptic, PPI, proton pump inhibitors, reflux, reflux disease, resection, squamous mucosa, strictures, survival, Swedish database, symptom control, Toupet fundoplication, ulcers, USC, valve
Overall incidence trend in esophageal adenocarcinoma–1:32 Cancer Epidemiol Biomarkers Prev 2010
Citation–4:08 Cancer Epidemiol 2018
Barrett’s etiology–5:16 Ann Surg 1992
PPIs & development of Barrett’s–11:22 Am J Gastroenterol 2006
Barrett’s progression to dysplasia & adenocarcinoma–13:11 Ann Surg 2007
Loss of LGD–15:22 Ann Surg 1998
Persistent dysplasia/progression to T1a adenocarcinoma–16:35
Conclusion–18:36
sages_adbutler_leaderboard